Health Canada has granted a Notice of Compliance (NOC) for Enhertu® (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...
The overall survival (OS) data has come in from the TROPION-Lung01 study of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) in lung cancer – and the result likely isn’t what they ...
Shimadzu Asia Pacific joins the global celebration of Shimadzu Corporation's 150th anniversary, marking a century and a half ...
Nkarta CEO Paul Hastings recently spoke to the importance of the industry's collaborations with Chinese biopharma companies.
Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.
TipRanks on MSN
Daiichi Sankyo’s Promising Study on Ifinatamab Deruxtecan: A Potential Game-Changer in Oncology
Daiichi Sankyo Company (($DSKYF)) announced an update on their ongoing clinical study. Daiichi Sankyo Company (DSKYF) is currently conducting a ...
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, recently presented preclinical data showing its proprietary antibody-drug ...
Actinium Pharmaceuticals (ATNM) announced the presentation of the first ever preclinical data of ATNM-400 in non-small cell lung cancer, or NSCLC.
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called ...
We project that in the next six weeks, the probability of a U.S. recession getting started in the next twelve months will be ...
The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap, but ...
United States 5-Year Bond Yield Stay on top of current and historical data relating to U.S. 5-Year Bond Yield. The yield on a Treasury bill represents the return an investor will receive by holding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results